| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.04 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.04 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.05 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.097 | 0.05 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.05 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.089 | 0.05 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.05 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.099 | 0.05 |